Effect of bortezomib on human neuroblastoma: analysis of molecular mechanisms involved in cytotoxicity
<p>Abstract</p> <p>Background</p> <p>Bortezomib, a specific and selective inhibitor of the 26S proteasome with antitumor activity against a wide range of malignancies, has been approved for the treatment of relapsed or refractory multiple myeloma and other cancers. Rece...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2008-06-01
|
| Series: | Molecular Cancer |
| Online Access: | http://www.molecular-cancer.com/content/7/1/50 |